Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Artemether/lumefantrine

First report of various toxicities: 16 case reports

    • 11 Accesses

    This is a preview of subscription content, log in to check access.

    REFERENCE

    1. 1.

      Kabanywanyi AM, Mulure N, Migoha C, Malila A, Lengeler C, Schlienger R, Genton B.Experience of safety monitoring in the context of a prospective observational study of artemether-lumefantrine in rural Tanzania: Lessons learned for pharmacovigilance reporting. Malaria Journal 9: 14 Jul 2010. Available from: URL: http://dx.doi.org/10.1186/1475-2875-9-205 - Tanzania

    Download references

    Rights and permissions

    Reprints and Permissions

    About this article

    Cite this article

    Artemether/lumefantrine. React. Wkly. 1321, 8 (2010). https://doi.org/10.2165/00128415-201013210-00016

    Download citation

    Keywords

    • Public Health
    • Adverse Event
    • Observational Study
    • Patient Outcome
    • Malaria